Being the sixth most diagnosed cancer and the fourth leading cause of cancer-related deaths worldwide, liver cancer is considered as a serious disease with a high prevalence and poor prognosis. Current anticancer drugs for liver cancer have drawbacks, such as limited efficacy in later stages of the disease, toxicity to healthy cells, and the potential for drug resistance. There is ample evidence that coumarin-based compounds are potent anticancer agents, with numerous analogues currently being investigated in preclinical and clinical studies.
View Article and Find Full Text PDFHepatocellular carcinoma (HCC), a highly malignant tumour with very high morbidity and mortality, remains the second cause of cancer-related deaths worldwide. Galangin is a naturally occurring flavonoid extracted from the propolis and root of Alpinia officinarum, which possesses antitumour efficacy, which has resulted in an increase in interest in related research. Additionally, galangin inhibits cell proliferation and induces apoptosis in several human malignancies.
View Article and Find Full Text PDFLuteolin (LUT) is a natural flavonoid with low oral bioavailability with restricted clinical applications due to its low solubility. LUT shows significant anti-tumor activity in many cancer cells, including hepatocellular carcinoma (HCC). The most recent trend in pharmaceutical innovations is the application of phospholipid vesicles to improve the solubility of such hydrophobic drugs.
View Article and Find Full Text PDFExcess iron causes cell injury by reacting with superoxide anions (O2*) and hydrogen peroxide (H2O2) and producing hydroxyl radical (OH*) and reactive oxygen species (ROS). In the present study, albino rats were fed with biscuits enriched with ferrous sulphate (0.3% w/w) for 10 weeks to have overload iron conditions and observed a significant decrease in serum chromium, brain serotonin and dopamine, while iron and zinc increased significantly in serum.
View Article and Find Full Text PDF